116 related articles for article (PubMed ID: 23560720)
1. Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
Davis A; Walsh M; McCarthy P; Brown G; Roberts S; Tran H; Street A; Fong CY; Kemp W
Haemophilia; 2013 Jul; 19(4):583-9. PubMed ID: 23560720
[TBL] [Abstract][Full Text] [Related]
2. Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Tomaszewski M; Bienz M; Kherad O; Restellini S; Laflèche T; Barkun A; Warner M; Bessissow T
Haemophilia; 2019 Mar; 25(2):289-295. PubMed ID: 30748066
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two doses of tranexamic acid on bleeding and surgery site quality during sinus endoscopy surgery.
Abbasi H; Behdad S; Ayatollahi V; Nazemian N; Mirshamsi P
Adv Clin Exp Med; 2012; 21(6):773-80. PubMed ID: 23457130
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
6. Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy.
Santagostino E; Mancuso ME; Morfini M; Schiavoni M; Tagliaferri A; Barillari G; Mannucci PM
Haematologica; 2006 May; 91(5):634-9. PubMed ID: 16670069
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic effect of tranexamic acid in elective nasal surgery.
Yaniv E; Shvero J; Hadar T
Am J Rhinol; 2006; 20(2):227-9. PubMed ID: 16686395
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
9. [Use of desmopressin in children with inherited platelet dysfunctions undergoing adenotonsillar procedures].
García-Matte RJ; Beltran MC; Fonseca X; Barriga F; Wietstruck A; Zúñiga P
Acta Otorrinolaringol Esp; 2012; 63(2):115-9. PubMed ID: 22153965
[TBL] [Abstract][Full Text] [Related]
10. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
12. Management of orthopaedic surgery in rare bleeding disorders.
Siboni SM; Biguzzi E; Pasta G; Mannucci PM; Mistretta C; Fantini NN; Solimeno LP; Peyvandi F
Haemophilia; 2014 Sep; 20(5):693-701. PubMed ID: 24612427
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
14. Effects of topical antifibrinolytics in endoscopic sinus surgery: a pilot randomized controlled trial.
Athanasiadis T; Beule AG; Wormald PJ
Am J Rhinol; 2007; 21(6):737-42. PubMed ID: 18201457
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid and thrombosis.
Prescrire Int; 2013 Jul; 22(140):182-3. PubMed ID: 23951593
[TBL] [Abstract][Full Text] [Related]
16. Management of children with inherited mild bleeding disorders undergoing adenotonsillar procedures.
García-Matte R; María Constanza Beltrán M; Ximena Fonseca A; Pamela Zúñiga C
Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):291-4. PubMed ID: 22188821
[TBL] [Abstract][Full Text] [Related]
17. [Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms].
Szczepanik AB; Wisławski S; Windyga J; Huszcza S; Bilski R; Meissner AJ
Pol Merkur Lekarski; 2009 Nov; 27(161):375-80. PubMed ID: 19999800
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic tranexamic acid decreases bleeding after cardiac operations.
Horrow JC; Hlavacek J; Strong MD; Collier W; Brodsky I; Goldman SM; Goel IP
J Thorac Cardiovasc Surg; 1990 Jan; 99(1):70-4. PubMed ID: 2403616
[TBL] [Abstract][Full Text] [Related]
19. [Comparative effect of tranexamic acid on the reduction of bleeding during and after cardiac surgery].
Okuyama K; Matsukawa T; Abe F; Kumazawa T
Masui; 1998 Jul; 47(7):861-4. PubMed ID: 9720336
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
Berntorp E; Windyga J;
Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
